BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24310984)

  • 1. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
    Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
    Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
    Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
    Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
    Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
    J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
    Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
    Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.
    Sova P; Feng Q; Geiss G; Wood T; Strauss R; Rudolf V; Lieber A; Kiviat N
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):114-23. PubMed ID: 16434596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation regulated microRNAs in human cervical cancer.
    Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
    Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
    Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
    Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
    van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
    Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
    Wu JH; Liang XA; Wu YM; Li FS; Dai YM
    Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
    Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
    Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
    Wang KH; Lin CJ; Liu CJ; Liu DW; Huang RL; Ding DC; Weng CF; Chu TY
    Cancer Med; 2015 Jan; 4(1):43-55. PubMed ID: 25418975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.
    Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY
    Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer.
    Farkas SA; Milutin-Gašperov N; Grce M; Nilsson TK
    Epigenetics; 2013 Nov; 8(11):1213-25. PubMed ID: 24030264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.
    Verlaat W; Snijders PJF; Novianti PW; Wilting SM; De Strooper LMA; Trooskens G; Vandersmissen J; Van Criekinge W; Wisman GBA; Meijer CJLM; Heideman DAM; Steenbergen RDM
    Clin Cancer Res; 2017 Jul; 23(14):3813-3822. PubMed ID: 28119363
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
    Wang SS; Smiraglia DJ; Wu YZ; Ghosh S; Rader JS; Cho KR; Bonfiglio TA; Nayar R; Plass C; Sherman ME
    Cancer Res; 2008 Apr; 68(7):2489-97. PubMed ID: 18381458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.